Pharmacokinetics, Safety, and Efficacy of ARQ-151 Once a Day in Adolescents and Children With Mild to Moderate Eczema
Condition: Atopic Dermatitis (Eczema) Intervention: Drug: ARQ-151 cream 0.15% Sponsor: Arcutis, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials